GPCR News 

December 2022 Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic...

November 2021 Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody...

November 2021 "Target class-specific libraries mean you need to screen less to identify high-quality antibodies. Aaron Sato, Chief...